Board Meeting13 May 2026, 06:51 pm
Metropolis Healthcare Approves FY26 Results, ₹1 Dividend
AI Summary
Metropolis Healthcare Ltd's board approved audited standalone and consolidated financial results for the quarter and year ended March 31, 2026. They declared a 2nd interim dividend of ₹1 per equity share with a record date of May 19, 2026. Deloitte Haskins & Sells LLP was recommended as the new statutory auditor, replacing B S R & Co. LLP. Dr. Nilesh Shah transitioned from President - Internal Assurance to an advisory role, ceasing to be Senior Management Personnel.
Key Highlights
- Audited FY26 standalone and consolidated financial results approved.
- Second interim dividend of ₹1 per share declared; record date is May 19, 2026.
- Deloitte Haskins & Sells recommended as new statutory auditors.
- Dr. Nilesh Shah transitions to advisory role, no longer Senior Management.
- B S R & Co. LLP completes second term as Statutory Auditors.
Price Impact
More from METROPOLIS